Biotech Investors & VC Firms in San Mateo
11 firms in this list, with a median first check of $375K. 5 of them lead rounds. Generated from verified public data and updated continuously.
Draper Associates
San MateoPre-Seed–Series A$500K – $5M
22 people
Portfolia
San MateoSeed–Late Stage$10K
79 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$5M – $500M
56 people
Sanderling Ventures
San MateoSeed–Late Stage$50K – $1M
8 people
Phoenix Venture Partners
San MateoPre-Seed–Growth$100K – $3M
16 people
Boost VC
San MateoPre-Seed–Seed$500K
10 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
6 people
Westlake International Group
San MateoPre-Seed–Series A
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $20M
33 people
GoAhead Ventures
Menlo ParkPre-Seed–Series A$500K – $1M
5 people
Shoreline Venture Management
San Francisco Bay AreaSeed–Growth$250K – $8M
11 people
Frequently asked questions
- Who are the top biotech investors & vc firms in san mateo?
- Top biotech investors & vc firms in san mateo include Draper Associates, Portfolia, Hercules Capital, Inc., Sanderling Ventures, Phoenix Venture Partners, Boost VC, Mohr Davidow Ventures, Westlake International Group — 11 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in san mateo?
- The median first check among the 11 biotech investors & vc firms in san mateo tracked here is $375K.
- How many biotech investors & vc firms in san mateo lead rounds?
- 5 of the 11 biotech investors & vc firms in san mateo tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.









































